Monday, July 27
Morning Session
Brain Tumor Funders’ Collaborative (BTFC) Members Only
Location: Commissioner’s Room
8:15 AM – 1:00 PM: BTFC Meeting
Afternoon Session
Open to All Attendees
Location: Arbor Ballroom
2:00 – 3:00 PM: Welcome & State of the Field: Nonprofit Updates
3:00 – 3:30 PM: Society for Neuro-Oncology (SNO) Community Updates
Sajeel A Chowdhary, MD, Director, Neuro-Oncology and Translational Research in Neuro-Oncology
Tampa General Hospital Cancer Institute (TGH CI), Tampa General Hospital (TGH) and Professor of Neurology and Neuro-Oncology, USF Health Morsani College of Medicine, University of South Florida (USF)
3:30 – 4:00 PM: Public Policy & Advocacy Updates
Gary Heimberg, MPA, JD, Chief Policy & Advocacy Officer, Counsel at National Brain Tumor Society (NBTS)
4:00 PM – 5:30 PM: Turning Science into Action: Aligning Research and Advocacy for Patient Impact
Roxana Dronca, MD, Director, Mayo Clinic Comprehensive Cancer Center in Florida; Paul Hull, PhD, Vice President of Regional Advocacy, American Cancer Society Cancer Action Network
Evening Reception
Open to All Attendees
Location: Cascades Deck
5:30 – 7:00 PM: Cocktail Reception & Dinner
Tuesday, July 28
Full-Day General Session – Open to All Attendees
Location: Arbor Ballroom
7:00 – 8:00 AM: Breakfast
8:00 – 9:00 AM: Welcome & State of the Field: Nonprofit Updates
9:00 – 10:00 AM: From Data to Discovery to Delivery: The CBTN Model in Action
Adam Resnick, PhD, Director, Center for Data-Driven Discovery in Biomedicine; Amanda Haddock, Founding Director and President, Dragon Master Initiative
10:00 – 10:30 AM: Pediatric Trials in Transition: Navigating a Changing Ecosystem
Amanda Haddock, Founding Director and President, Dragon Master Initiative; Misha Mehta, PhD, Sr. Director of Research, Pediatric Brain Tumor Foundation; Kim Wallgren, Executive Director, The CERN Foundation, a Program of the National Brain Tumor Society
10:30 – 10:45 AM: SNO Update
Chas Haynes, JD, Executive Director, Society for Neuro-Oncology
10:45 – 11:15 AM: Listening Session: Strengthening Partnership Across the Brain Tumor Community
Kelly Sitkin, President & Chief Executive Officer, American Brain Tumor Association (ABTA)
11:15 – 11:45 AM: Data that Drives Decisions: Insights from Central Brain Tumor Registry of the United States
Carol Kruchko, President & Chief Mission Officer, Central Brain Tumor Registry of the United States (CBTRUS)
11:45 – 1:00 PM: Lunch
1:00 – 2:30 PM: Too Old, Too Young, Too Overlooked: The AYA Reality in Brain Tumors
Alex Berkovits, LCSW, OSW-C, Lead Neuro-Oncology Social Work Navigator, Brain Tumor Network; Bradley Gampel, MD, MS, Pediatric and AYA Neuro-Oncologist, University of Miami Sylvester Comprehensive Cancer Center; Jaclyn Murphy, Founder, Friends of Jaclyn Foundation; Byram Ozer, MD, PhD, Associate Professor of Hematology and Medical Oncology and Neurology, Emory University School of Medicine; Co-Director, Neuro-Oncology Program, and Director of Translational Research in Neuro-Oncology, Winship Cancer Institute of Emory University; Jessica Schulte, MD, PhD, Director of AYA Neuro-Oncology, NYU Brain & Spine Tumor Center; Kee Kiat (Aaron) Yeo, MD, Pediatric Neuro-Oncologist and Adolescent and Young Adult Neuro-Oncology Program Director, Dana-Farber Cancer Institute
2:30 – 3:00 PM: Networking Break
3:00 – 4:30 PM: Turning Insight into Action: Working Session on AYA Issues
4:30 – 5:30 PM: Closing Toast